Archive — US — techcrunch
Giraffe Bio aims its bespoke biomolecules at the looming copper shortage
Giraffe Bio is innovating copper extraction by creating bespoke biomolecules to improve recovery rates by up to 5%. With copper demand projected to outstrip supply by 2040, their technology utilizes engineered compounds rather than conventional microbes. Recently, they raised $6.4 million to scale their solutions, promising enhanced efficiency while replacing harmful chemicals in mining processes.
Key points
- Copper demand is set to exceed supply by 25% by 2040 due to the AI and electrification boom.
- Traditional mining methods opening new mines are costly with only 0.3% success.
- Giraffe Bio develops specific biomolecules that improve copper recovery rates by up to 5%.
- The company has raised $6.4 million in a seed round, led by Orion Industrial Ventures.
- Their approach reduces reliance on live microbes and can be adapted for gold and silver.
- The compounds enhance the flotation process in mining, targeting only copper and eliminating harmful chemicals.
Why it matters
- Historically, mining has faced sustainability challenges with environmental impacts.
- The 2025 IT Trends indicate a growing reliance on innovative technological solutions in resource extraction.
- Biotechnology in mining aligns with the increasing demand for eco-friendly practices and solutions.
Giraffe Bio's innovative biomolecular approach marks a significant advancement in sustainable mining, addressing looming copper shortages and minimizing environmental harm while potentially reshaping the future of mineral extraction.